ACE Report Cover
Minimally invasive percutaneous plate osteosynthesis vs. ORIF for distal tibia fractures
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Language
Download Download Download
Download
Cite this Report Cite this Report Cite this Report
Cite
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favorites
TRAUMA
Minimally invasive percutaneous plate osteosynthesis vs. ORIF for distal tibia fractures .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2013;1(16):48 Injury. 2013 Aug;44(8):1102-6.
Contributing Authors

J Zou W Zhang CQ Zhang

94 patients with displaced extra-articular distal tibia fractures were randomized to receive open reduction and internal fixation (ORIF) or treatment using a minimally invasive percutaneous plate osteosynthesis (MIPPO). This one year study aimed to evaluate the clinical success of the minimally invasive operation in comparison to ORIF, assessing differences in complications and operative outcomes. The results demonstrated similar outcomes for ORIF and the MIPPO procedure, unless a Type C fracture was involved, in which case, the healing time was reduced with the MIPPO approach.


Publication Funding Details +
Funding:
Not Reported
Conflicts:
None disclosed

Risk of Bias

5.5/10

Reporting Criteria

16/20

Fragility Index

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Yes = 1

Uncertain = 0.5

Not Relevant = 0

No = 0

The Reporting Criteria Assessment evaluates the transparency with which authors report the methodological and trial characteristics of the trial within the publication. The assessment is divided into five categories which are presented below.

1/4

Randomization

3/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

The Fragility Index is a tool that aids in the interpretation of significant findings, providing a measure of strength for a result. The Fragility Index represents the number of consecutive events that need to be added to a dichotomous outcome to make the finding no longer significant. A small number represents a weaker finding and a large number represents a stronger finding.

Why was this study needed now?

Patients with tibial fractures can be treated operatively with a minimally invasive approach or with open reduction and internal fixation. Minimally invasive percutaneous plate osteosynthesis (MIPPO) can potentially reduce periosteal damage and improve direct bone healing while reducing recovery time. MIPPO is widely accepted and regularly used to treat fractures of the extremities; however, it is not confirmed as to whether the minimally invasive approach is superior to the absolute stability of open surgery. Therefore, this study was required to compare the clinical outcomes of MIPPO and ORIF for displaced extra-articular distal tibia fractures.

What was the principal research question?

Will a minimally invasive percutaneous plate osteosynthesis approach provide greater success in treating a displaced extra-articular distal tibia fracture compared to open reduction and internal fixation?

Study Characteristics +
Population:
94 patients presented with displaced extra-articular distal tibia fractures between the ages of 18 and 60 years.
Intervention:
Closed (MIPPO) Group: Minimally invasive percutaneous plate osteosynthesis was performed on these patients. Two 3-4 cm incisions were made in the medial tibia followed by a subcutaneous incision between the two points. This allowed the plate to be inserted percutaneously parallel to the tibia axial line. Mean Age = 46.5 (Range 39-54) years, 75% male, (n=52). (for further detail consult the original publication)
Comparison:
Open (ORIF) Group: The incision of these patients was initiated lateral of the anterior tibia crest and stretches to the medial malleolus followed by separation of the soft tissue allowing direct access to the fracture. Plates were placed on the medial surface of the tibia. Mean age = 46 (Range 36-54) years, 64.3% male, (n=42). (for further detail consult the original publication)
Outcomes:
Primary Outcomes: Frequency of delayed union, non-union and malunion. Secondary Outcomes: Duration of operation, recovery speed and operational bleeding.
Methods:
RCT; Single-Center; single-blind
Time:
Postoperative assessments made at 2 weeks and 4 weeks followed by monthly examinations up to 12 months.
What were the important findings?
  • Complications occurred at a similar rate with 9 occurring in the open group and 10 in the closed group. However, the distribution of these complications was significantly different between groups (p=0.028)
  • In the closed group, there was 1 non-union, 4 delayed unions, 5 malunions and 0 infections. In the open group there were 4 non-unions, 3 delayed unions, 0 malunions and 2 infections.
  • There was no difference in the operational bleeding between the two approaches (p=0.150).
  • Operative time was significantly longer in the open group (65.0 min) than in the closed group (56 min) (p<0.001)
  • Subgroup analysis assessing AO fracture types indicated similar recovery times for fracture types A and B; however, type C fractures treated with the minimally invasive approach had a significantly shorter recovery time (p=0.032).
What should I remember most?

Minimally invasive percutaneous plate osteosynthesis (MIPPO) for the treatment of displaced extra-articular distal tibia fractures produced similar results compared to open reduction and internal fixation. A similar rate of complication was shown; however, there was a difference in the distribution of these complications between the two groups. Analysis of fracture healing based on fracture classification indicated that in Type C fractures; MIPPO resulted in a shorter healing times.

How will this affect the care of my patients?

Minimally invasive percutaneous plate osteosynthesis produced similar results when compared to ORIF for patients with extra-articular distal tibia fractures. However, patients with type C fractures may benefit from a shorter healing time when operated on using the minimally invasive percutaneous plate osteosynthesis approach. Further research needs to be undertaken to assess if healing time remains improved in patients with type C fractures when assessed in a larger sample of patients. Additionally, the functional outcomes of minimally invasive techniques and ORIF need to be compared and further assessments of complication rates are required.

DISCLAIMER

This content found on this page is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. If you require medical treatment, always seek the advice of your physician or go to your nearest emergency department. The opinions, beliefs, and viewpoints expressed by the individuals on the content found on this page do not reflect the opinions, beliefs, and viewpoints of OrthoEvidence.

0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Your account will be affiliated with
and includes free access to OrthoEvidence


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

How to cite this ACE Report

OrthoEvidence. Minimally invasive percutaneous plate osteosynthesis vs. ORIF for distal tibia fractures. OE Journal. 2013;1(16):48. Available from: https://myorthoevidence.com/AceReport/Show/

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report